Clearing up potential misconceptions about the treatment of rheumatoid arthritis and the use of methotrexate in combination therapy

Abstract

Get full access to this article

View all access options for this article.

References

McInnes

O’Dell

. State-of-the art: rheumatoid arthritis. Ann Rheum 2010;69(11):1898-906. [Erratum, Ann Rheum Dis 2011;70(2):399.]

O’Dell

. Treatment of rheumatoid arthritis. In: Firestein

Budd

Gabriel

McInnes

O’Dell

, eds. Kelley’s textbook of rheumatology. 9th ed. Philadelphia (PA): Elsevier; 2013:1137-60.

Singh

Furst

Bharata

et al . 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625-39.

Smolen

Landewe

Bijlsma

et al . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960-77.

Singh

Saag

Bridges

Jr et al . 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016;68(1):1-26.

Bykerk

Akhavan

Hazlewood

et al . Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39(8):1559-82.

Smolen

Breedveld

Burmester

et al . EULAR T2T: treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016:75:3.15.

Stoffer

Schoels

Smolen

et al . Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis 2016;75(1):16-22.

Hazlewood

Barnabe

Tomlinson

et al . Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: a network meta-analysis. Cochrane Database Syst Rev 2016;8:CD010227.

10.

Gabay

Emery

van Vollenhoven

et al . Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. Lancet 2013;381:1541-650.

11.

Klareskog

van der Heijde

de Jager

et al . Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis. Lancet 2004;363:675-81.

12.

Jani

Barton

Warren

et al . The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatology 2014;53(2):213-22.

13.

Nam

Takase-Minegishi

Ramiro

et al . Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2017;76(6):1113-36.

14.

Chatzidionysiou

Emamikia

Nam

et al . Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying anti-rheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2017;76(6):1102-7.

15.

Desai

Thaler

Mahlknecht

et al . Comparative risk of harm associated with use of targeted immunomodulators: a systematic review. Arthritis Care Res (Hoboken) 2016;68(8):1078-88.

16.

Charles-Schoeman

Burmester

Nash

et al . Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2016;75:1293-301.

17.

Pincus

Gibson

Castrejon

. Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull Hosp Joint Dis 2013;71(suppl 1):S9-19.

18.

Goekoop-Ruiterman

YPM

de Vries- Bouwstra

Allaart

et al . Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52(11):3381-90.

19.

Van Vollenhoven

Ernestam

Geborek

et al . Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomized trial. Lancet 2009;374(3988):459-66.

20.

Hall

Bolina

Chatterley

Jamali

. Interaction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitors: a narrative review of the literature. Ann Pharmacother 2017;51(2):163-78.

21.

Bornstein

Craig

Tin

. Practice guidelines for pharmacists: the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. Can Pharm J (Ott) 2014;147(2):97-109.

22.

Drugs for the management of rheumatoid arthritis: clinical evaluation—project protocol. Ottawa (ON): CADTH; 2016. Available: https://www.cadth.ca/dv/drugs-management-rheumatoid-arthritis-clinical-evaluation-project-protocol (accessed May 28, 2017).

23.

Patel

. Communicating across cultures: proceedings of a workshop to assess health literacy and cross-cultural communication skills. J Pharm Pract Res 2015;45:49-56.

24.

Kleinman

Eisenberg

Good

. Culture, illness and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978;88(2):251-8.

25.

The 4C’s of culture. Available: www.ggalanti.org/the-4cs-of-culture/ (accessed May 28, 2018).

26.

de Klerk

van der Heijde

van der Tempel

et al . Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol 1999;26(12):2635-41.

27.

Morisky

Green

Levine

. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67-74.

28.

Fialko

Garety

Kuipers

et al . A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res 2008;100(1-3):53-9.

29.

de Klerk

van der Heijde

Landewe

et al . The compliance questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 2003;30(11):2469-75.

30.

Butler

Peveler

Roderick

et al . Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004;77(5):786-9.